Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 13811-711

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 13811-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trigen Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Image (Methylphenidate HCl Extended Release Tablets 1)

Chemical structure diagram of methylphenidate hydrochloride, showing the molecular components including a phenyl ring, ester group, piperidine ring, and hydrochloride salt.*

FDA Label Image

Figure 1 (Methylphenidate HCl Extended Release Tablets 2)

A line graph comparing mean plasma methylphenidate concentration (ng/mL) over time (hours) for two regimens: 18 mg once daily extended-release tablets and 5 mg three times daily immediate-release doses. The graph shows concentration changes from 0 to 32 hours post-dose for both dosing schedules.*

FDA Label Image

Figure 2 (Methylphenidate HCl Extended Release Tablets 3)

A bar graph comparing inattention and overactivity symptom scores on a scale from 0 to 15 between methylphenidate hydrochloride extended-release tablets once daily and placebo groups across three studies. The graph shows symptom scores for Study 1, Study 2, and Study 3 (Week 4), with lower scores generally observed in the methylphenidate groups compared to placebo.*

FDA Label Image

Figure 3 (Methylphenidate HCl Extended Release Tablets 4)

A line graph comparing combined attention subscale scores over 12 hours post initial dose between methylphenidate hydrochloride extended-release tablets and placebo. The x-axis represents hours post initial dose, and the y-axis represents attention levels from less attentive to more attentive. Data points show greater attention improvement with placebo than methylphenidate tablets across time, with standard error bars included.*

FDA Label Image

Trigen Logo (Methylphenidate HCl Extended Release Tablets 5)

FDA Label Image

Trigen Logo (Methylphenidate HCl Extended Release Tablets 6)

FDA Label Image

Methylphenidate 45 mg 30ct Bl 200306-1 Rev. 06/2022 (Methylphenidate HCl Extended Release Tablets 7)

Methylphenidate Hydrochloride 45 mg extended-release tablets label from Trigen Laboratories, LLC. The label states a package size of 30 tablets with Rx only. Storage instructions include keeping the package child-resistant and protecting it from moisture, with a recommended temperature range of 20° to 25°C (68° to 77°F).*

FDA Label Image

Methylphenidate 63 mg 30ct Bl 200307-1 Rev. 062022 (Methylphenidate HCl Extended Release Tablets 8)

Label for Methylphenidate Hydrochloride extended-release tablets, 63 mg strength. The label includes dosage instructions, storage conditions (20° to 25°C), child-resistant packaging notice, and manufacturer information for Trigen Laboratories, LLC. The package contains 30 tablets and is marked Rx only. A barcode and NDC 13811-700-30 are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.